ID   4G4 [Mouse hybridoma against marinobufagenin]
AC   CVCL_B0LB
SY   MBG4G4
DR   ATCC; PTA-6725
DR   Wikidata; Q108819663
RX   Patent=US8038997;
RX   PubMed=19008721;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6725.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI:146151; Marinobufagenin (MBG).
CC   Misspelling: MGB4G4; ATCC=PTA-6725.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 5
//
RX   Patent=US8038997;
RA   Bagrov A.Y., Fedorova O.V., Lakatta E.G., Simbirtsev A.S., Kotov A.Y.,
RA   Kolodkin N.I.;
RT   "Anti-marinobufagenin antibodies and methods for their use.";
RL   Patent number US8038997, 18-Oct-2011.
//
RX   PubMed=19008721; DOI=10.1097/HJH.0b013e328312c86a;
RA   Fedorova O.V., Simbirtsev A.S., Kolodkin N.I., Kotov A.Y.,
RA   Agalakova N.I., Kashkin V.A., Tapilskaya N.I., Bzhelyansky A.,
RA   Reznik V.A., Frolova E.V., Nikitina E.R., Budny G.V., Longo D.L.,
RA   Lakatta E.G., Bagrov A.Y.;
RT   "Monoclonal antibody to an endogenous bufadienolide, marinobufagenin,
RT   reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood
RT   pressure in NaCl-sensitive hypertension.";
RL   J. Hypertens. 26:2414-2425(2008).
//